Cold agglutinin syndrome in pediatric liver transplant recipients.
Anemia is a common finding in post-liver transplant patients. Causes for the anemia include nutritional deficiencies, red cell aplasia as well as immune-mediated hemolysis. One of the immunologic causes of hemolytic anemia is drug-induced hemolysis. Tacrolimus is a common immunosuppressant used in post-liver transplant patients to prevent graft rejection. There have been reports of tacrolimus-associated hemolytic anemia secondary to hemolytic uremic syndrome as well as autoimmune hemolysis. There are also case-reports of severe hemolytic anemia related to cold agglutinin production in post-liver transplant patients. We described in this paper three cases of severe cold agglutinin hemolytic anemia in three pediatric liver transplant patients. Steroid therapy, plasmapheresis and withdrawal of tacrolimus led to resolution of the severe hemolytic process in each case. Whether the immune-mediated hemolysis is related to tacrolimus is not clear and needs to be characterized further.
Wong
Wendy
W
Division of Pediatric Hematology, Stanford University Medical Center, Stanford, California 94305, USA. wendyw@stanford.edu
Merker
Jason D
JD
Nguyen
Christine
C
Berquist
William
W
Jeng
Michael
M
Viele
Maurene
M
Glader
Bertil
B
Fontaine
Magali J
MJ
D000373:Agglutinins / Q000096:biosynthesis; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000209:etiology* / Q000628:therapy; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D017114:Liver Failure, Acute / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects*; D010956:Plasmapheresis / Q000379:methods; D013577:Syndrome
D000373:Agglutinins; D005938:Glucocorticoids; D007166:Immunosuppressive Agents